The FASTRACK II study by Shankar Siva and colleagues1 provided short-term evidence of renal tumour sensitivity to high-dose radiation in the non-surgical treatment of T1 renal tumours.
The FASTRACK II study by Shankar Siva and colleagues1 provided short-term evidence of renal tumour sensitivity to high-dose radiation in the non-surgical treatment of T1 renal tumours.
For Additional News from OncWeekly – Your Front Row Seat To The Future of Cancer Care –
Trusted insights straight to your inbox and get the latest updates from OncWeekly
Privacy Policy